# Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain

> **NCT00911287** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 129 (actual)

## Conditions studied

- Pain
- Chronic Disease

## Interventions

- **DRUG:** Oxymorphone extended release

## Key facts

- **NCT ID:** NCT00911287
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-01
- **Final completion:** 2004-03
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2010-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911287, "Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00911287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*